ArticleOsteoarthritis and cartilage open2024

A phase III study to evaluate the long-term safety and efficacy of fasinumab in patients with pain due to osteoarthritis of the knee or hip.

Stephen J DiMartino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.